Log in to save to my catalogue

Therapeutic RNA-silencing oligonucleotides in metabolic diseases

Therapeutic RNA-silencing oligonucleotides in metabolic diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2633858152

Therapeutic RNA-silencing oligonucleotides in metabolic diseases

About this item

Full title

Therapeutic RNA-silencing oligonucleotides in metabolic diseases

Author / Creator

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2022-06, Vol.21 (6), p.417-439

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Recent years have seen unprecedented activity in the development of RNA-silencing oligonucleotide therapeutics for metabolic diseases. Improved oligonucleotide design and optimization of synthetic nucleic acid chemistry, in combination with the development of highly selective and efficient conjugate delivery technology platforms, have established a...

Alternative Titles

Full title

Therapeutic RNA-silencing oligonucleotides in metabolic diseases

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2633858152

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2633858152

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/s41573-022-00407-5

How to access this item